文献速递呼吸危重症与机械通气

ARDS研究五十年:基因组学的贡献与机遇

Fifty Years of Research in ARDS. Genomic Contributions and Opportunities.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01

临床因素难以单独解释急性呼吸窘迫综合征(ARDS)的发病风险与结局。过去20年,ARDS基因组学研究从候选基因关联研究转向无偏倚方法发现新候选基因,并日益关注功能后果与因果推断。尽管样本量、表型异质性和早期肺组织匮乏等挑战限制应用,遗传研究仍为阐明ARDS发病机制和精准医学提供独特贡献。

要点

  • 临床因素对ARDS风险和结局解释力有限。
  • ARDS基因组学已从候选基因研究转向无偏倚方法。
  • 遗传研究助力阐明ARDS发病机制与精准医学。

核心结论

  • 临床因素难以充分解释ARDS风险与结局,遗传研究为发病机制和精准医学提供独特贡献。

研究设计与样本

  • 综述类文章,回顾过去20年ARDS基因组学研究进展,未报告具体样本量。

主要发现

  • 过去20年识别出众多与ARDS相关的基因和遗传变异。
  • 研究方法从候选基因关联研究转向无偏倚方法识别新候选基因。
  • 日益关注显著关联背后的功能后果,并应用因果推断方法。

临床怎么用

  • 遗传研究有望推动ARDS精准医学,但当前证据尚不支持直接用于临床决策。

局限性

  • 样本量挑战、已知和未知的表型异质性、早期ARDS肺组织匮乏限制基因组学应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical factors alone poorly explain acute respiratory distress syndrome (ARDS) risk and ARDS outcome. In the search for individual factors that may influence ARDS risk, the past 20 years have witnessed the identification of numerous genes and genetic variants that are associated with ARDS. The field of ARDS genomics has cycled from candidate gene association studies to bias-free approaches that identify new candidates, and increasing effort is made to understand the functional consequences that may underlie significant associations. More recently, methodologies of causal inference are being applied to maximize the information gained from genetic associations. Although challenges of sample size, both recognized and unrecognized phenotypic heterogeneity, and the paucity of early ARDS lung tissue limit some applications of the rapidly evolving field of genomic investigation, ongoing genetic research offers unique contributions to elucidating ARDS pathogenesis and the paradigm of precision ARDS medicine.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Reilly JP, Christie JD, Meyer NJ, et al. Fifty Years of Research in ARDS. Genomic Contributions and Opportunities. Am J Respir Crit Care Med. 2017. PMID: 28481621. doi:10.1164/rccm.201702-0405CP

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。